Physician profile
Ronald Brent New
NPI 1912019019
$60,870.09
in general payments reported to CMS, 2019-2025
34 companies · $4,389 in 2025
The $4,389 reported for 2025 was more than what 80% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,274 · 2020: $2,792 · 2021: $4,154 · 2022: $11K · 2023: $19K · 2024: $16K · 2025: $4,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Education: $5,500 · Travel and Lodging: $4,943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,202.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,687.50 |
| Education | $5,500.00 |
| Travel and Lodging | $4,942.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,157.73 | 2021-2025 | Corevalve Evolut R, Avalus, Na |
| Intuitive Surgical, INC. | $9,680.32 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic Vascular, INC. | $4,601.09 | 2019-2020 | |
| Abiomed | $3,423.14 | 2019-2025 | Impella |
| Abbott Laboratories | $2,952.47 | 2019-2025 | Epic, Mitraclip, Navitor |
| Atricure, INC. | $2,589.86 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Kls-Martin L.P. | $1,124.22 | 2021-2025 | |
| Edwards Lifesciences Corporation | $1,060.35 | 2019-2025 | Sapien 3 Ultra Resilia |
| Corcym INC | $844.02 | 2022-2024 | Perceval |
| Getinge USA Sales, LLC | $344.04 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Bolton Medical INC | $264.47 | 2019-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Davol INC. | $214.09 | 2019-2023 | Progel Applicator Spray Tips |
| Zimmer Biomet Holdings, INC. | $183.45 | 2019-2025 | Sternalock Blu System |
| Baxter Healthcare | $168.91 | 2019-2024 | Preveleak |
| Teleflex LLC | $161.03 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $142.85 | 2023-2024 | Tagrisso |
| Medical Device Business Services, INC. | $124.99 | 2024 | Ethicon |
| Angiodynamics, INC. | $118.91 | 2019-2021 | |
| Cook Medical LLC | $110.36 | 2019 | |
| La Jolla Pharmaceutical Company | $109.28 | 2024-2025 | Giapreza |
| Biostable Science & Engineering | $84.07 | 2019 | |
| W. L. Gore & Associates, INC. | $74.58 | 2019-2021 | |
| Ethicon US, LLC | $58.98 | 2023-2025 | Evarrest, Prolene, Vistaseal |
| Lsi Solutions INC | $45.54 | 2022 | |
| Mission Medical Distribution, LLC | $38.30 | 2024 | |
| Livanova USA, INC. | $33.11 | 2019 | |
| Stryker Corporation | $28.48 | 2025 | Na |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.30 | 2023 | Lifevest |
| Dilon Technologies, INC. | $23.22 | 2024 | Hemoblast Bellows |
| Chiesi USA, INC. | $23.05 | 2022 | |
| Artivion, INC. | $17.32 | 2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cardiac Non-Synergraft, Amds-Ascyrus Medical |
| Pulmonx Corporation | $15.75 | 2021 | |
| Covidien LP | $14.05 | 2020 | |
| Clearflow INC. | $13.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald New listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.